The surveillance agency of Brazil's Ministry of Health (Anvisa) suspended on Thursday the distribution and commercialization of the meningococcal serogroup C conjugate vaccine Meningitec, following a global recall by its owner Nuron Biotech Inc., of Exton, Pa.